Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform’s AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients’ cardiovascular risk better than the best clinical standards. Read this case study for lessons learned.
Related articles
-
Looking for a better way to manage data across your environments? 📊 DM us to discuss how @Azure Arc makes setting up a hybrid infrastructure easier.
-
Family-owned Berryessa Gap Vineyards empowers its mobile workforce and enhances the customer experience with Microsoft 365 and Teams | Microsoft Customer Stories
-
Security Is Only as Strong as the Weakest Link